Gross Profit (TTM) Chart

View Gross Profit (TTM) for DERM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit (TTM) Chart
Start Trial

Historical Gross Profit (TTM) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 40.40M
March 31, 2026 38.01M
December 31, 2025 36.68M
September 30, 2025 35.06M
June 30, 2025 33.59M
March 31, 2025 32.90M
December 31, 2024 31.83M
September 30, 2024 33.11M
June 30, 2024 51.88M
March 31, 2024 52.97M
December 31, 2023 52.52M
September 30, 2023 51.53M
June 30, 2023 32.31M
Date Value
March 31, 2023 33.56M
December 31, 2022 42.89M
September 30, 2022 42.64M
June 30, 2022 42.19M
March 31, 2022 39.33M
December 31, 2021 31.05M
September 30, 2021 32.50M
June 30, 2021 30.12M
March 31, 2021 28.61M
December 31, 2020 29.94M
September 30, 2020 20.49M
June 30, 2020 14.43M
March 31, 2020 8.136M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Nektar Therapeutics 53.90M
ANI Pharmaceuticals, Inc. 505.18M
Corcept Therapeutics, Inc. 816.73M
Veru, Inc. -0.113M
Johnson & Johnson 66.63B